vs

Side-by-side financial comparison of Core Natural Resources, Inc. (CNR) and West Pharmaceutical Services (WST). Click either name above to swap in a different company.

Core Natural Resources, Inc. is the larger business by last-quarter revenue ($1.0B vs $805.0M, roughly 1.3× West Pharmaceutical Services). West Pharmaceutical Services runs the higher net margin — 16.4% vs -7.6%, a 24.0% gap on every dollar of revenue. On growth, Core Natural Resources, Inc. posted the faster year-over-year revenue change (81.8% vs 7.5%). West Pharmaceutical Services produced more free cash flow last quarter ($175.0M vs $26.0M). Over the past eight quarters, Core Natural Resources, Inc.'s revenue compounded faster (38.1% CAGR vs 7.6%).

Arch Resources, previously known as Arch Coal, was an American coal mining and processing company. The company mined, processed, and marketed bituminous and sub-bituminous coal with low sulfur content in the United States. Arch Resources was the second-largest supplier of coal in the United States, behind Peabody Energy. As of 2011 the company supplied 15% of the domestic market. Demand came mainly from generators of electricity.

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin.

CNR vs WST — Head-to-Head

Bigger by revenue
CNR
CNR
1.3× larger
CNR
$1.0B
$805.0M
WST
Growing faster (revenue YoY)
CNR
CNR
+74.2% gap
CNR
81.8%
7.5%
WST
Higher net margin
WST
WST
24.0% more per $
WST
16.4%
-7.6%
CNR
More free cash flow
WST
WST
$149.0M more FCF
WST
$175.0M
$26.0M
CNR
Faster 2-yr revenue CAGR
CNR
CNR
Annualised
CNR
38.1%
7.6%
WST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNR
CNR
WST
WST
Revenue
$1.0B
$805.0M
Net Profit
$-79.0M
$132.1M
Gross Margin
37.8%
Operating Margin
-9.3%
19.5%
Net Margin
-7.6%
16.4%
Revenue YoY
81.8%
7.5%
Net Profit YoY
-356.3%
1.5%
EPS (diluted)
$-1.51
$1.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNR
CNR
WST
WST
Q4 25
$1.0B
$805.0M
Q3 25
$1.0B
$804.6M
Q2 25
$1.1B
$766.5M
Q1 25
$1.0B
$698.0M
Q4 24
$573.6M
$748.8M
Q3 24
$553.4M
$746.9M
Q2 24
$490.7M
$702.1M
Q1 24
$546.7M
$695.4M
Net Profit
CNR
CNR
WST
WST
Q4 25
$-79.0M
$132.1M
Q3 25
$31.6M
$140.0M
Q2 25
$-36.6M
$131.8M
Q1 25
$-69.3M
$89.8M
Q4 24
$30.8M
$130.1M
Q3 24
$95.6M
$136.0M
Q2 24
$58.1M
$111.3M
Q1 24
$101.9M
$115.3M
Gross Margin
CNR
CNR
WST
WST
Q4 25
37.8%
Q3 25
36.6%
Q2 25
35.7%
Q1 25
33.2%
Q4 24
36.5%
Q3 24
35.4%
Q2 24
32.8%
Q1 24
33.1%
Operating Margin
CNR
CNR
WST
WST
Q4 25
-9.3%
19.5%
Q3 25
-1.2%
20.8%
Q2 25
-1.7%
20.1%
Q1 25
-5.3%
15.3%
Q4 24
6.6%
21.3%
Q3 24
21.2%
21.6%
Q2 24
14.6%
18.0%
Q1 24
22.7%
17.7%
Net Margin
CNR
CNR
WST
WST
Q4 25
-7.6%
16.4%
Q3 25
3.2%
17.4%
Q2 25
-3.3%
17.2%
Q1 25
-6.8%
12.9%
Q4 24
5.4%
17.4%
Q3 24
17.3%
18.2%
Q2 24
11.8%
15.9%
Q1 24
18.6%
16.6%
EPS (diluted)
CNR
CNR
WST
WST
Q4 25
$-1.51
$1.82
Q3 25
$0.61
$1.92
Q2 25
$-0.70
$1.82
Q1 25
$-1.38
$1.23
Q4 24
$1.04
$1.78
Q3 24
$3.22
$1.85
Q2 24
$1.96
$1.51
Q1 24
$3.39
$1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNR
CNR
WST
WST
Cash + ST InvestmentsLiquidity on hand
$432.2M
$791.3M
Total DebtLower is stronger
$354.2M
$202.8M
Stockholders' EquityBook value
$3.7B
$3.2B
Total Assets
$6.1B
$4.3B
Debt / EquityLower = less leverage
0.10×
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNR
CNR
WST
WST
Q4 25
$432.2M
$791.3M
Q3 25
$444.7M
$628.5M
Q2 25
$413.2M
$509.7M
Q1 25
$388.5M
$404.2M
Q4 24
$460.2M
$484.6M
Q3 24
$331.7M
$490.9M
Q2 24
$216.1M
$446.2M
Q1 24
$172.6M
$601.8M
Total Debt
CNR
CNR
WST
WST
Q4 25
$354.2M
$202.8M
Q3 25
$334.5M
$202.7M
Q2 25
$334.0M
$202.6M
Q1 25
$329.8M
$202.6M
Q4 24
$94.8M
$202.6M
Q3 24
$83.7M
$202.6M
Q2 24
$184.9M
$205.8M
Q1 24
$185.5M
$206.2M
Stockholders' Equity
CNR
CNR
WST
WST
Q4 25
$3.7B
$3.2B
Q3 25
$3.8B
$3.1B
Q2 25
$3.8B
$2.9B
Q1 25
$3.9B
$2.7B
Q4 24
$1.6B
$2.7B
Q3 24
$1.5B
$2.8B
Q2 24
$1.4B
$2.6B
Q1 24
$1.4B
$2.7B
Total Assets
CNR
CNR
WST
WST
Q4 25
$6.1B
$4.3B
Q3 25
$6.2B
$4.1B
Q2 25
$6.2B
$4.0B
Q1 25
$6.3B
$3.6B
Q4 24
$2.9B
$3.6B
Q3 24
$2.8B
$3.7B
Q2 24
$2.7B
$3.5B
Q1 24
$2.7B
$3.6B
Debt / Equity
CNR
CNR
WST
WST
Q4 25
0.10×
0.06×
Q3 25
0.09×
0.07×
Q2 25
0.09×
0.07×
Q1 25
0.08×
0.08×
Q4 24
0.06×
0.08×
Q3 24
0.05×
0.07×
Q2 24
0.13×
0.08×
Q1 24
0.13×
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNR
CNR
WST
WST
Operating Cash FlowLast quarter
$107.3M
$251.1M
Free Cash FlowOCF − Capex
$26.0M
$175.0M
FCF MarginFCF / Revenue
2.5%
21.7%
Capex IntensityCapex / Revenue
7.8%
9.5%
Cash ConversionOCF / Net Profit
1.90×
TTM Free Cash FlowTrailing 4 quarters
$21.2M
$468.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNR
CNR
WST
WST
Q4 25
$107.3M
$251.1M
Q3 25
$87.9M
$197.2M
Q2 25
$220.2M
$177.1M
Q1 25
$-109.6M
$129.4M
Q4 24
$121.3M
$190.1M
Q3 24
$161.3M
$180.1M
Q2 24
$116.3M
$165.0M
Q1 24
$77.5M
$118.2M
Free Cash Flow
CNR
CNR
WST
WST
Q4 25
$26.0M
$175.0M
Q3 25
$38.6M
$133.9M
Q2 25
$131.0M
$101.9M
Q1 25
$-174.5M
$58.1M
Q4 24
$80.5M
$85.2M
Q3 24
$121.9M
$98.8M
Q2 24
$60.9M
$64.8M
Q1 24
$35.1M
$27.6M
FCF Margin
CNR
CNR
WST
WST
Q4 25
2.5%
21.7%
Q3 25
3.9%
16.6%
Q2 25
11.9%
13.3%
Q1 25
-17.1%
8.3%
Q4 24
14.0%
11.4%
Q3 24
22.0%
13.2%
Q2 24
12.4%
9.2%
Q1 24
6.4%
4.0%
Capex Intensity
CNR
CNR
WST
WST
Q4 25
7.8%
9.5%
Q3 25
4.9%
7.9%
Q2 25
8.1%
9.8%
Q1 25
6.4%
10.2%
Q4 24
7.1%
14.0%
Q3 24
7.1%
10.9%
Q2 24
11.3%
14.3%
Q1 24
7.7%
13.0%
Cash Conversion
CNR
CNR
WST
WST
Q4 25
1.90×
Q3 25
2.78×
1.41×
Q2 25
1.34×
Q1 25
1.44×
Q4 24
3.94×
1.46×
Q3 24
1.69×
1.32×
Q2 24
2.00×
1.48×
Q1 24
0.76×
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNR
CNR

Other$397.4M38%
Power Generation$376.5M36%
PRB$183.0M18%
Metallurgical$42.0M4%
Industrial$34.1M3%
Terminal Revenue$6.4M1%
Other Revenue$3.0M0%

WST
WST

Proprietary Products$661.8M82%
Contract Manufactured Products$143.2M18%
Affiliated Entity$3.3M0%

Related Comparisons